Skip to content

Evaluation of a Mobile Digital Solution for Cancer Care and Research

Evaluation of a Mobile Digital Solution for Cancer Care and Research: A Feasibility Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03094741
Enrollment
30
Registered
2017-03-29
Start date
2017-04-01
Completion date
2020-11-05
Last updated
2021-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Caregivers, Quality of Life

Brief summary

The primary purpose of this pilot study is to evaluate the feasibility and acceptability of a Mobile Digital Solution in monitoring and collecting symptom burden data. The proposed study is meant to be the preparatory work for an intervention study to test the effect of Mobile Digital Solutions on improving patient outcomes by prompting early interventions for symptom relief and support of patient and family caregiver quality of life (QOL).

Detailed description

Demographic information and patient-reported symptoms will be collected from study participants through a mobile health application called CancerLife that they can download (FREE) from their mobile device app store (Android or iOS). Participants will be asked to broadcast their emotional and physical status through a list of symptom list within the app as well as how that symptom is impacting their quality of life and activities of daily living. This data will be collected inside the application and display in easy to understand pie charts. Participants will also have the option to broadcast their entry to their social network. Since the objective of the current feasibility study is to evaluate the feasibility and acceptability of a Mobile Digital Solution in monitoring and collecting symptom burden and QOL data, the investigators will include a standard validated instrument (FACT-G: Functional Assessment of Cancer Therapy - General) as part of this study. Participants will be asked to complete the FACT-G after initial registration and weekly for up to 4 weeks. Participants will receive electronic mail messages with a link to CancerLife weekly as a reminder to access the website.

Interventions

CancerLife is a mobile digital solution that allows patients to broadcast their health status inside a private invitation only group, text, email or publicly in Facebook or Instagram. By doing, so the patient collects his/her own patient-reported outcomes data and then share this data with their doctor or care team.

Sponsors

CancerLife
CollaboratorUNKNOWN
Saint John's Cancer Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Established diagnosis of cancer * Karnofsky Index ≥50% * Age \> 18 years

Exclusion criteria

* Relevant cognitive impairment * Insufficient knowledge of English language to complete the survey

Design outcomes

Primary

MeasureTime frameDescription
Feasibility/ Participation Rate4 weeksnumber of individuals who participate in the study divided by the number of individuals who opened the link

Secondary

MeasureTime frameDescription
Open Rate4 weeksnumber of individuals who open the link divided by total number of individuals reached by the advertisement
Refusal rate4 weeksnumber of individuals who declined to participate divided by the number of individuals who opened the link
Retention rate4 weeksnumber of mission data divided by total number of items available
Rate of missing data4 weeksnumber of mission data divided by total number of items available
Participant Satisfaction4 weeksdescribe the usability, satisfaction, and desirability of the Mobile Digital Solution using a patient experience survey at the end of the study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026